On 23rd June 2025, it was announced that people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. However, the national roll out does not mean all people will be able to get a prescription for tirzepatide (Mounjaro®) on this day.

Weight management services are locally commissioned at an Integrated Care Board (ICB) level. In mid and south Essex, access to tirzepatide will initially be through specialist weight management services only. Access to tirzepatide (Mounjaro®) through primary care is not expected to start in mid and south Essex until later in 2025.

NHS Mid and South Essex ICB has provided information on tirzepatide on its website - Visit the website for more information.

The following dates below are our time to learn dates. During this time, the surgery will close from 1pm in the afternoon for staff training. Our services are covered by NHS 111, so please give 111 a call if you require medical attention or pop along to your local pharmacy for some advice. If your medical condition is more serious, then please visit A and E and you will receive care and treatment from the hospital. 

March 4th 2025

April 1st 2025

May 13th 2025

June 3rd 2025

July 1st 2025

September 9th 2025

October 7th 2025

November 4th 2025

December 2nd 2025

January 6th 2026

February 3rd 2026

March 3rd 2026

 Please note, these dates are subject to change, under the instructions of the ICB.

It is the responsibility of the patient to ensure the surgery is informed of any change in telephone number or address to ensure the practice holds the correct information in patients clinical record.

It is the responsibility of the patient to ensure you contact the practice for any test results that were organised for you from the surgery,

to ensure you receive your result in a timely manner.